Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B


Koklu S., Gulsen M. T. , Tuna Y., Koklu H., Yuksel O., Demir M., ...More

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.41, no.3, pp.310-319, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1111/apt.13036
  • Journal Name: ALIMENTARY PHARMACOLOGY & THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.310-319
  • Süleyman Demirel University Affiliated: Yes

Abstract

BackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection.